Reckitt Launches Maternal & Child Health Tech Accelerator

Reckitt Launches Maternal & Child Health Tech Accelerator

India Pharma Outlook Team | Thursday, 11 September 2025

 Maternal & Child Health

Reckitt has also joined with PATH and the Centre of Health Research and Innovation (CHRI) to start the Dettol Banega Swasth India - Maternal and Child Health Tech Accelerator. This platform creates an opportunity to invite the most innovative ideas of India to create solutions aimed at early health, and development over the first 1,000 days of life in under-served communities. The accelerator is designed to give mothers, caregivers, frontline health workers, and public health systems more power and empower the ecosystem in 500 aspirational blocks of India.

In line with the Viksit Bharat 2047, the government has ensured access to quality healthcare to millions of mothers and infants by undertaking several initiatives, among them, Ayushman Bharat PM-JAY, Ayushman Bharat Digital Mission, eSanjeevani Telemedicine Service, and the Universal Immunization Programme.

Gaurav Jain, Executive Vice President - South Asia, Reckitt, said, “At Reckitt, our purpose is to protect, heal, and nurture in the relentless pursuit of a cleaner, healthier world that aligns closely with the Government of India’s vision to ensure every citizen has access to quality and affordable healthcare. We believe that access to the highest standards of hygiene should be a right, not a privilege. Through the Dettol Banega Swasth India - Maternal and Child Health Tech Accelerator, in partnership with PATH-CHRI, we aim to bridge the gap between innovation and impact."

"This initiative is about transforming bold ideas into scalable, real-world solutions that reach the last mile, strengthening systems, improving lives, and supporting India’s journey toward Viksit Bharat @2047. Together, our success will continue to positively impact communities, building an ecosystem where health and hygiene are universally accessible,” he added.

Also Read: Dr Reddy's Buys Stugeron Brand from Johnson & Johnson

Neeraj Jain, Director of Growth Operations - Asia, Middle East and Europe, PATH, added, “At PATH-CHRI, we believe that innovation and collaboration are the twin engines that drive public health impact. We are proud to partner with Reckitt for the Dettol Banega Swasth India – Maternal and Child Health Tech Accelerator, an important step toward reimagining how we deliver on the promise of the first 1,000 days of life."

The accelerator will shortlist innovators for a pitch event in September, with the top five solutions implemented in partnership with Plan India to enhance maternal and child health outcomes nationwide.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.